Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Congress
Responsibility in Drug Advertising Act of 2016 – Introduced to…
United States House of Representatives member Rosa DeLauro introduced a bill the Responsibility in Drug Advertising Act …
Congress Seeks Feedback on Site-Neutral Provision of Bipartisan Budget Act…
House Energy and Commerce Committee Chairman, Representative Fred Upton, and Subcommittee on Health Chairman,…
Senate HELP Committee Moves Closer to Creating Corollary to 21st Century…
Last week, the Senate Health, Education, Labor, and Pensions (HELP) Committee approved a series of seven bills to work…
BioSimilars: FDA Panel Overwhelming Recommends Approval of Remicade…
Yesterday an FDA Advisory panel overwhelmingly recommended the Celltrion/Pfizer biosimilar Remsima 21-3 for approval for…
An Update on the Nomination of FDA Commissioner Robert Califf
An increasing number of senators are threatening to block Dr. Robert Califf's nomination to be the next Commissioner of…
Testy Oversight and Government Reform Committee Hearing on Prescription…
The United States House Oversight and Government Reform Committee held a hearing on developments in the prescription…
Senators Wyden and Grassley Request Public Comments on Gilead Pricing
On the heels of their December 1, 2015, report on Gilead Sciences' pricing of Hepatitis C drugs Sovaldi and Harvoni,…
Improving Regulatory Transparency for New Medical Therapies Act
President Obama recently signed the Improving Regulatory Transparency for New Medical Therapies Act into law. The Act…
Senate Aging Committee Hearing on Drug Prices: Faster Generics Approval…
The Senate Special Committee on Aging held a hearing on Wednesday, December 9, 2015, to discuss "Sudden Price Spikes in…
Senators McCain and Grassley Request HHS for Approval of Importation of…
As the controversy over drug pricing continues to heat up, Senators Chuck Grassley and John McCain have started to place…